Inbox Robot - Choose newsletter content

Choose content

Enter keywords to create a newsletter

Create account

Enter your registration information

Set preferences

Set up your newsletter name, delivery and time zone preferences

Hint: Enter different keywords to generate new results.

Now you can:

Search the news index.
Browse more than 1 million newsletters by category.
Use preset newsletters:
- Human Genome Sciences Shares

Human Genome Sciences Shares Newsletter

The CFO at one of the largest law firms in the U.S. shares his philosophy for thriving as a self-described introvert: ‘I do not do work dinners’ 21 Aug 2023 13:43 GMT
Good morning. Are you able to bring your authentic self to work each day? If you ask William M. Washington III, global CFO at Baker McKenzie, an international law firm, he’ll tell you that embracing introversion is a part of creating an inclusive …
GSK to acquire Human Genome Sciences for US$14.25 per share in cash 16 Jul 2012 14:12 GMT
… plc (LSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today … 2.5 billion in shares in 2012. Sir Andrew … , approximately 427,042 shares had been tendered and … . HGS, Human Genome Sciences and BENLYSTA ® are trademarks of Human Genome Sciences, Inc. Other …
GSK sets 20 July for expiration of tender offer to acquire Human Genome Sciences 29 Jun 2012 19:11 GMT
… acquire all of the outstanding shares of Human Genome Sciences (NASDAQ: HGSI) for US …
GSK continues with tender offer to acquire all outstanding shares of Human Genome Sciences 15 Jun 2012 14:10 GMT
… received a renewed invitation from Human Genome Sciences’ (NASDAQ: HGSI) to participate in … acquire all of the outstanding shares of HGS for US$13 …
GSK extends tender offer for all outstanding shares of Human Genome Sciences 08 Jun 2012 13:10 GMT
… acquire all of the outstanding shares of Human Genome Sciences (NASDAQ: HGSI) for US … , approximately 474,029 shares (including 24,856 shares subject to guarantees of …
GSK statement on tender offer to acquire Human Genome Sciences 17 May 2012 17:10 GMT
… (LSE: GSK) today commented on Human Genome Sciences (NASDAQ: HGSI) Board of Directors … acquire all of the outstanding shares of HGS for US$13 …
GSK commences tender offer to acquire Human Genome Sciences for US $13.00 per share in cash 10 May 2012 12:10 GMT
… acquire all of the outstanding shares of Human Genome Sciences (NASDAQ: HGSI) for US …
GSK to commence tender offer to acquire Human Genome Sciences for US $13.00 per share in cash 09 May 2012 07:10 GMT
… it will not participate in Human Genome Sciences (NASDAQ: HGSI) strategic alternatives review … acquire all of the outstanding shares of HGS for US$13 …

Satisfied with the content?

Continue to create your account.

Choose content

Create account

Set preferences

EIN MARKETING SOLUTIONS

EIN NEWS SERVICES

ALL NEWS PUBLICATIONS